<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2017-6-124-131</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-1897</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОНКОГЕМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ONCOHEMATOLOGY</subject></subj-group></article-categories><title-group><article-title>ДИФФЕРЕНЦИАЛЬНАЯ ДИАГНОСТИКА ЛИМФОМ СРЕДОСТЕНИЯ: ВЗГЛЯД ОНКОЛОГА И ПАТОЛОГА</article-title><trans-title-group xml:lang="en"><trans-title>DIFFERENTIAL DIAGNOSIS OF LYMPHOMAS OF THE MEDIASTINUM: A VIEW OF THE ONCOLOGIST AND PATHOLOGIST</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ХАРЧЕНКО</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>KHARCHENKO</surname><given-names>E. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>АРТЕМЬЕВА</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>ARTEMYEVA</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>PhD in medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>СЕМИГЛАЗОВА</surname><given-names>Т. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>SEMIGLAZOVA</surname><given-names>T. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="en"><p>MD, Prof.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>КЛИМАШЕВСКИЙ</surname><given-names>В. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>KLIMASHEVSKY</surname><given-names>V. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>PhD in medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>АЛЕКСЕЕВ</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>ALEXEEV</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>PhD in medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ЗЮЗГИН</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>ZYUZGIN</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>PhD in medicine</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ФИЛАТОВА</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>FILATOVA</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н.</p></bio><bio xml:lang="en"><p>MD</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>МОТАЛКИНА</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>MOTALKINA</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>СЕМИГЛАЗОВ</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>SEMIGLAZOV</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, чл.-корр. РАН</p></bio><bio xml:lang="en"><p>MD, Prof., Corresponding member of RAS</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ЧУДИНОВСКИХ</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>CHUDINOVSKY</surname><given-names>Y. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ЗВЯГИНЦЕВА</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>ZVYAGINTSEVA</surname><given-names>D. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ХАДОНОВ</surname><given-names>У. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>KHADONOV</surname><given-names>U. B.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ШИЛО</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>SHILO</surname><given-names>P. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>КУШНАРЕВ</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>KUSHNAREV</surname><given-names>V. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>КОСИЧКИНА</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>KOSICHKINA</surname><given-names>A. B.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт онкологии им. Н.Н. Петрова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petrov Research Institute of Oncology, St. Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт онкологии им. Н.Н. Петрова Минздрава России&#13;
&#13;
Северо-Западный государственный медицинский университет им. И.И. Мечникова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petrov Research Institute of Oncology, St. Petersburg&#13;
&#13;
Mechnikov North-Western State Medical University of the Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт онкологии им. Н.Н. Петрова Минздрава России&#13;
&#13;
Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petrov Research Institute of Oncology, St. Petersburg&#13;
&#13;
Pavlov First Saint-Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2017</year></pub-date><volume>0</volume><issue>6</issue><fpage>124</fpage><lpage>131</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; ХАРЧЕНКО Е.В., АРТЕМЬЕВА А.С., СЕМИГЛАЗОВА Т.Ю., КЛИМАШЕВСКИЙ В.Ф., АЛЕКСЕЕВ С.М., ЗЮЗГИН И.С., ФИЛАТОВА Л.В., МОТАЛКИНА М.С., СЕМИГЛАЗОВ В.В., ЧУДИНОВСКИХ Ю.А., ЗВЯГИНЦЕВА Д.А., ХАДОНОВ У.Б., ШИЛО П.С., КУШНАРЕВ В.А., КОСИЧКИНА А.Б., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">ХАРЧЕНКО Е.В., АРТЕМЬЕВА А.С., СЕМИГЛАЗОВА Т.Ю., КЛИМАШЕВСКИЙ В.Ф., АЛЕКСЕЕВ С.М., ЗЮЗГИН И.С., ФИЛАТОВА Л.В., МОТАЛКИНА М.С., СЕМИГЛАЗОВ В.В., ЧУДИНОВСКИХ Ю.А., ЗВЯГИНЦЕВА Д.А., ХАДОНОВ У.Б., ШИЛО П.С., КУШНАРЕВ В.А., КОСИЧКИНА А.Б.</copyright-holder><copyright-holder xml:lang="en">KHARCHENKO E.V., ARTEMYEVA A.S., SEMIGLAZOVA T.Y., KLIMASHEVSKY V.F., ALEXEEV S.M., ZYUZGIN I.S., FILATOVA L.V., MOTALKINA M.S., SEMIGLAZOV V.V., CHUDINOVSKY Y.A., ZVYAGINTSEVA D.A., KHADONOV U.B., SHILO P.S., KUSHNAREV V.A., KOSICHKINA A.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/1897">https://www.med-sovet.pro/jour/article/view/1897</self-uri><abstract><p>В данной статье рассмотрена дифференциальная диагностика клинических, патоморфологических и иммуногистохимических особенностей различных типов лимфом средостения с точки зрения онколога и патолога. При изолированном поражении органов средостения клинико-рентгенологическая диагностика затруднена, только развернутый гистологический диагноз позволяет определиться с тактикой и подобрать эффективную терапию. Образования средостения часто выявляются у лиц молодого трудоспособного возраста, и большинство из них – лимфопролиферативные заболевания. Спектр лимфом, возникающих в средостении, широк, чаще всего это крупноклеточные В-клеточные лимфомы, к которым помимо лимфомы Ходжкина относятся первичная медиастинальная крупноклеточная В- клеточная лимфома, диффузная крупноклеточная В-клеточная лимфома и медиастинальная лимфома серой зоны. Кроме того, в средостении могут возникать другие В-клеточные индолентные неходжкинские лимфомы и Т-клеточные лимфомы.</p></abstract><trans-abstract xml:lang="en"><p>The clinic-rentgenological differential diagnosis is difficult especially in case of localized mediastinal disease. Just detailed histological diagnosis allows making a right tactic decision and choosing effective therapy. Furthermore, some indolent B-cell lymphomas and T-cell lymphomas can arise in mediastinum. Mediastinal tumors are frequent in young adults, and most of these neoplasms are lymphoproliferative disorders. The spectrum of mediastinal lymphoma is broad. The most often of them are large B-cell lymphomas: classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, diffuse large B-cell lymphoma and mediastinal grey zone lymphoma.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лимфомы средостения</kwd><kwd>лимфома Ходжкина</kwd><kwd>В-клеточная лимфома</kwd><kwd>Т-клеточная лимфома</kwd><kwd>дифференциальная диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mediastinal lymphoma</kwd><kwd>Hodgkin lymphoma</kwd><kwd>B-cell lymphoma</kwd><kwd>Т-cell lymphoma</kwd><kwd>differential diagnosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shimosato Y, Mukai K, Matsuno Y. Tumors of the Mediastinum, Atlas of Tumor Pathology, AFIP Fourth Series, Fascicle 11, 2010.</mixed-citation><mixed-citation xml:lang="en">Shimosato Y, Mukai K, Matsuno Y. Tumors of the Mediastinum, Atlas of Tumor Pathology, AFIP Fourth Series, Fascicle 11, 2010.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal R, Rao S, Chopra P et al. Morphological spectrum of mediastinal lesions with special emphasis on evaluation of needle biopsy: An experience from a tertiary care hospital. Indian J. Med. Res., 2016, 144(4): 544-51.</mixed-citation><mixed-citation xml:lang="en">Aggarwal R, Rao S, Chopra P et al. Morphological spectrum of mediastinal lesions with special emphasis on evaluation of needle biopsy: An experience from a tertiary care hospital. Indian J. Med. Res., 2016, 144(4): 544-51.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Petkoviс I. Current trends in the treatment of primary mediastinal large B-cell lymphoma an overview. Contemp. Oncol. (Pozn), 2015, 19(6): 428-35.</mixed-citation><mixed-citation xml:lang="en">Petkoviс I. Current trends in the treatment of primary mediastinal large B-cell lymphoma an overview. Contemp. Oncol. (Pozn), 2015, 19(6): 428-35.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Aggarwal R, Rao S, Dhawan S et al. Primary mediastinal lymphomas, their morphological features and comparative evaluation. Lung India, 2017, 34(1): 19-24.</mixed-citation><mixed-citation xml:lang="en">Aggarwal R, Rao S, Dhawan S et al. Primary mediastinal lymphomas, their morphological features and comparative evaluation. Lung India, 2017, 34(1): 19-24.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Savage KJ, Al-Rajhi N, Voss N et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann. Oncol., 2006, 17(1): 123-30.</mixed-citation><mixed-citation xml:lang="en">Savage KJ, Al-Rajhi N, Voss N et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann. Oncol., 2006, 17(1): 123-30.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Juanpere S, Cañete N, Ortuño P et al. A diagnostic approach to the mediastinal masses. Insights Imaging., 2013, 4(1): 29-52.</mixed-citation><mixed-citation xml:lang="en">Juanpere S, Cañete N, Ortuño P et al. A diagnostic approach to the mediastinal masses. Insights Imaging., 2013, 4(1): 29-52.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Eichenauer DA, Engert A, André M et al. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann. Oncol., 2014, 25(suppl. 3): 70-5.</mixed-citation><mixed-citation xml:lang="en">Eichenauer DA, Engert A, André M et al. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann. Oncol., 2014, 25(suppl. 3): 70-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dunleavy K, Wilson W. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood, 2015, 125(1): 33-9.</mixed-citation><mixed-citation xml:lang="en">Dunleavy K, Wilson W. Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? Blood, 2015, 125(1): 33-9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hutchinson C, Wang Е. Primary мediastinal (thymic) large B-Cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma. Arch. Pathol. Lab. Med., 2011, 135(3): 394-8.</mixed-citation><mixed-citation xml:lang="en">Hutchinson C, Wang Е. Primary мediastinal (thymic) large B-Cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma. Arch. Pathol. Lab. Med., 2011, 135(3): 394-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non- Hodgkin’s lymphoma. Am. J. Med., 1993, 94(2): 133-9.</mixed-citation><mixed-citation xml:lang="en">Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non- Hodgkin’s lymphoma. Am. J. Med., 1993, 94(2): 133-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Palutke M, Tranchida L. T-cell lymphoma: report of a case. Am. J. Clin. Pathol., 1975, 64(1): 26-33.</mixed-citation><mixed-citation xml:lang="en">Palutke M, Tranchida L. T-cell lymphoma: report of a case. Am. J. Clin. Pathol., 1975, 64(1): 26-33.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Borowitz M, Chan J: T lymphoblastic leukaemia/lymphoma. In Swerdlow S et al. WHO classification: tumors of hematopoietic and lymphoid tissues, 2008, IARC.</mixed-citation><mixed-citation xml:lang="en">Borowitz M, Chan J: T lymphoblastic leukaemia/lymphoma. In Swerdlow S et al. WHO classification: tumors of hematopoietic and lymphoid tissues, 2008, IARC.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hashimoto M, Yamashita Y, Mori Y. Immunohistochemical detection of СD 79a expression in precursor T cell lymphoblastic lymphoma/ leukemias. J. Pathol., 2002, 197(3): 341-7.</mixed-citation><mixed-citation xml:lang="en">Hashimoto M, Yamashita Y, Mori Y. Immunohistochemical detection of СD 79a expression in precursor T cell lymphoblastic lymphoma/ leukemias. J. Pathol., 2002, 197(3): 341-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukemia. Nat. Rev. Cancer., 2006, 6(5): 347-59.</mixed-citation><mixed-citation xml:lang="en">Grabher C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukemia. Nat. Rev. Cancer., 2006, 6(5): 347-59.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pletneva MA, Smith LB. Anaplastic large cell lymphoma: features presenting diagnostic challenges. Arch. Pathol. Lab. Med., 2014, 138(10): 1290-4.</mixed-citation><mixed-citation xml:lang="en">Pletneva MA, Smith LB. Anaplastic large cell lymphoma: features presenting diagnostic challenges. Arch. Pathol. Lab. Med., 2014, 138(10): 1290-4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pan Z, Hu S, Li M et al. ALK-positive Large B-cell Lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am. J. Surg. Pathol., 2017, 41(1): 25-38.</mixed-citation><mixed-citation xml:lang="en">Pan Z, Hu S, Li M et al. ALK-positive Large B-cell Lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am. J. Surg. Pathol., 2017, 41(1): 25-38.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatt VR, Mourya R, Shrestha R, Armitage JO. Primary mediastinal large B-cell lymphoma. Cancer Treat. Rev., 2015, 41(6): 476-85.</mixed-citation><mixed-citation xml:lang="en">Bhatt VR, Mourya R, Shrestha R, Armitage JO. Primary mediastinal large B-cell lymphoma. Cancer Treat. Rev., 2015, 41(6): 476-85.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.3 (08.07.2016). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu ,accessed on 28/10/2016.</mixed-citation><mixed-citation xml:lang="en">Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.3 (08.07.2016). Association of the Nordic Cancer Registries. Danish Cancer Society. Available from http://www.ancr.nu ,accessed on 28/10/2016.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tilly H, Gomes da Silva M, Vitolo U et al. A diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2015, 26(suppl. 5): 116-25.</mixed-citation><mixed-citation xml:lang="en">Tilly H, Gomes da Silva M, Vitolo U et al. A diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2015, 26(suppl. 5): 116-25.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Puvvada S, Kendrick S, Rimsza L. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B-cell lymphoma. Cancer Genetics., 2013, 206(2): 257- 65.</mixed-citation><mixed-citation xml:lang="en">Puvvada S, Kendrick S, Rimsza L. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B-cell lymphoma. Cancer Genetics., 2013, 206(2): 257- 65.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk. Lymphoma, 2003, 44(suppl. 3): 41-7.</mixed-citation><mixed-citation xml:lang="en">Rosenwald A, Staudt LM. Gene expression profiling of diffuse large B-cell lymphoma. Leuk. Lymphoma, 2003, 44(suppl. 3): 41-7.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Leich E, Hartmann ME, Burek C et al. Diagnostic and prognostic significance of gene expression profiling in lymphomas. APMIS, 2007, 115: 1135-1146.</mixed-citation><mixed-citation xml:lang="en">Leich E, Hartmann ME, Burek C et al. Diagnostic and prognostic significance of gene expression profiling in lymphomas. APMIS, 2007, 115: 1135-1146.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Perry AM, Mitrovic Z, Chan WC. Biological prognostic markers in diffuse large B-cell lymphoma. Cancer Control., 2012, 19(3): 214-26.</mixed-citation><mixed-citation xml:lang="en">Perry AM, Mitrovic Z, Chan WC. Biological prognostic markers in diffuse large B-cell lymphoma. Cancer Control., 2012, 19(3): 214-26.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lichtenstein A, Levine A, Taylor C et al. Primary mediastinal lymphoma in adults. Am. J. Med., 1980, 68: 509-14.</mixed-citation><mixed-citation xml:lang="en">Lichtenstein A, Levine A, Taylor C et al. Primary mediastinal lymphoma in adults. Am. J. Med., 1980, 68: 509-14.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ferry JA. Extranodal lymphoma. Arch. Pathol. Lab. Med., 2008, 132(4): 565-78.</mixed-citation><mixed-citation xml:lang="en">Ferry JA. Extranodal lymphoma. Arch. Pathol. Lab. Med., 2008, 132(4): 565-78.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am. J. Surg. Pathol., 1986, 10(3): 176-91.</mixed-citation><mixed-citation xml:lang="en">Perrone T, Frizzera G, Rosai J. Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am. J. Surg. Pathol., 1986, 10(3): 176-91.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chan JK. Mediastinal large B-cell lymphoma: new evidence in support of its distinctive identity. Adv. Anat. Pathol., 2000, 7(4): 201-9.</mixed-citation><mixed-citation xml:lang="en">Chan JK. Mediastinal large B-cell lymphoma: new evidence in support of its distinctive identity. Adv. Anat. Pathol., 2000, 7(4): 201-9.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Matrtelli M, Ferreri AJ, Johonson P. Primary mediastinal B-cell lymphoma. Crit. Rev. Oncol. Hematol., 2008, 68(3): 256-63.</mixed-citation><mixed-citation xml:lang="en">Matrtelli M, Ferreri AJ, Johonson P. Primary mediastinal B-cell lymphoma. Crit. Rev. Oncol. Hematol., 2008, 68(3): 256-63.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Menestrina F, Chilosi M, Bonetti F et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology, 1986, 10(6): 589-600.</mixed-citation><mixed-citation xml:lang="en">Menestrina F, Chilosi M, Bonetti F et al. Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases. Histopathology, 1986, 10(6): 589-600.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Savage KJ. Primary mediastinal large B-cell lymphoma. Oncologist, 2006, 11(5): 488-95.</mixed-citation><mixed-citation xml:lang="en">Savage KJ. Primary mediastinal large B-cell lymphoma. Oncologist, 2006, 11(5): 488-95.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Swerdlow SH, Campo E, Harris N et al. World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, 2008.</mixed-citation><mixed-citation xml:lang="en">Swerdlow SH, Campo E, Harris N et al. World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, 2008.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon, IARC Press, 2004.</mixed-citation><mixed-citation xml:lang="en">Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon, IARC Press, 2004.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Кременецкая А.М., Пивник А.В., Куликов С.М. и др. Лечение больных первичной медиастинальной В-клеточной лимфосаркомой со склерозом программами первой линии. Гемато логия и трансфузиология, 2001, 6(1): 10-14.</mixed-citation><mixed-citation xml:lang="en">Кременецкая А.М., Пивник А.В., Куликов С.М. и др. Лечение больных первичной медиастинальной В-клеточной лимфосаркомой со склерозом программами первой линии. Гемато логия и трансфузиология, 2001, 6(1): 10-14.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Мазурок Л.А. Клинико-иммунологические особенности неходжкинских лимфом с первичным поражением средостения: автореф. дисс... канд. мед. наук. М., 2006. 29 с.</mixed-citation><mixed-citation xml:lang="en">Мазурок Л.А. Клинико-иммунологические особенности неходжкинских лимфом с первичным поражением средостения: автореф. дисс... канд. мед. наук. М., 2006. 29 с.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Savage KJ, Al-Rajhi N, Voss N et al. Favorable outcome of primary mediastinal large B- cell lymphoma in a single institution: the British Columbia experience. Ann. Oncol., 2006, 17(1): 123-30.</mixed-citation><mixed-citation xml:lang="en">Savage KJ, Al-Rajhi N, Voss N et al. Favorable outcome of primary mediastinal large B- cell lymphoma in a single institution: the British Columbia experience. Ann. Oncol., 2006, 17(1): 123-30.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Todeschini G, Secchi S, Morra E et al. Primary mediastinal large B-cell lymphoma: long- term results from retrospective multicentere Italian experience in 138 patients trated with CHOP or MACOP-B/VACOP-B. Br. J. Cancer, 2004, 90(2): 372-76.</mixed-citation><mixed-citation xml:lang="en">Todeschini G, Secchi S, Morra E et al. Primary mediastinal large B-cell lymphoma: long- term results from retrospective multicentere Italian experience in 138 patients trated with CHOP or MACOP-B/VACOP-B. Br. J. Cancer, 2004, 90(2): 372-76.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Isaacson PG, Spenser J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology, 1987, 11: 445-662.</mixed-citation><mixed-citation xml:lang="en">Isaacson PG, Spenser J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology, 1987, 11: 445-662.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Isaacson PG, Chan JK, Tang C, Addis BJ. Lowgrade B-cell lymphoma of mucosa- associated lymphoid tissue arising in the thymus. Am. J. Surg. Pathol., 1990, 14: 342-51.</mixed-citation><mixed-citation xml:lang="en">Isaacson PG, Chan JK, Tang C, Addis BJ. Lowgrade B-cell lymphoma of mucosa- associated lymphoid tissue arising in the thymus. Am. J. Surg. Pathol., 1990, 14: 342-51.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sunohara M, Hara K, Osamura K et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. Intern. Med., 2009, 48(23): 2025-32.</mixed-citation><mixed-citation xml:lang="en">Sunohara M, Hara K, Osamura K et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. Intern. Med., 2009, 48(23): 2025-32.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Nagasaka T, Lai R, Harada T et al. Coexisting thymic and gasric lymphomas of mucosa- associated lymphoid tissues in a patient with Sjogren’s syndrome. Arch. Pathol. Lab. Med., 2000, 124: 770-3.</mixed-citation><mixed-citation xml:lang="en">Nagasaka T, Lai R, Harada T et al. Coexisting thymic and gasric lymphomas of mucosa- associated lymphoid tissues in a patient with Sjogren’s syndrome. Arch. Pathol. Lab. Med., 2000, 124: 770-3.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffe ES, Harris NL, Stein H et al. WHO Classification Tumors. Pathology and genetics of tumors of hematopoetic and lymphoid tissues. Lyon: IARC Press, 2001.</mixed-citation><mixed-citation xml:lang="en">Jaffe ES, Harris NL, Stein H et al. WHO Classification Tumors. Pathology and genetics of tumors of hematopoetic and lymphoid tissues. Lyon: IARC Press, 2001.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Warnke RA, Weiss LM, Chan JK et al. Tumors of the lymph nodes and spleen. Atlas of tumor pathology, 3rd series, Fascicle 14, Washington DC: Armed Institute of Pathology, 1995.</mixed-citation><mixed-citation xml:lang="en">Warnke RA, Weiss LM, Chan JK et al. Tumors of the lymph nodes and spleen. Atlas of tumor pathology, 3rd series, Fascicle 14, Washington DC: Armed Institute of Pathology, 1995.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">King RL, Howard MT, Bagg A. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors. Adv. Anat. Pathol., 2014, 21(1): 12-25.</mixed-citation><mixed-citation xml:lang="en">King RL, Howard MT, Bagg A. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors. Adv. Anat. Pathol., 2014, 21(1): 12-25.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Shahid R, Gulzar R, Avesi L et al. Immunohistochemical Profile of Hodgkin and Non- Hodgkin Lymphoma. J. Coll. Physicians Surg. Pak., 2016, 26(2): 103-7.</mixed-citation><mixed-citation xml:lang="en">Shahid R, Gulzar R, Avesi L et al. Immunohistochemical Profile of Hodgkin and Non- Hodgkin Lymphoma. J. Coll. Physicians Surg. Pak., 2016, 26(2): 103-7.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Поддубная И.В., Савченко В.Г. Российские клинические рекомендации по диагностике и лечению лимфопролиферативных заболеваний. Современная онкология. М.: Медиа Медика, 2013. 104 с.</mixed-citation><mixed-citation xml:lang="en">Поддубная И.В., Савченко В.Г. Российские клинические рекомендации по диагностике и лечению лимфопролиферативных заболеваний. Современная онкология. М.: Медиа Медика, 2013. 104 с.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Артемьева А.С., Семиглазова Т.Ю., Франк Г.А. В-клеточные лимфомы средостения из крупных клеток. Вопр. онкологии, 2015, 61(2): 280-8.</mixed-citation><mixed-citation xml:lang="en">Артемьева А.С., Семиглазова Т.Ю., Франк Г.А. В-клеточные лимфомы средостения из крупных клеток. Вопр. онкологии, 2015, 61(2): 280-8.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Артемьева А.С., Моталкина М.С., Семиглазова Т.Ю. и др. Клинико- морфологические особенности медиастинальной лимфомы серой зоны. Врач, 2015, 9: 59-63.</mixed-citation><mixed-citation xml:lang="en">Артемьева А.С., Моталкина М.С., Семиглазова Т.Ю. и др. Клинико- морфологические особенности медиастинальной лимфомы серой зоны. Врач, 2015, 9: 59-63.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Артемьева А.С. Дифференциальная диагностика В-клеточных лимфом средостения из крупных клеток: автореф. дисс... канд. мед. наук. СПб., 2015. 43 с.</mixed-citation><mixed-citation xml:lang="en">Артемьева А.С. Дифференциальная диагностика В-клеточных лимфом средостения из крупных клеток: автореф. дисс... канд. мед. наук. СПб., 2015. 43 с.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
